Evidence-first health & aging science Newsletter
Live Well News Live Well News
Home
Longevity
Biological age & clocksHealthspan & frailtyHealth & inequalityMedicines & safety
Nutrition
Diet patternsFood & disease riskProcessed food & drinksGut health & digestion
Supplements
Vitamins & mineralsPerformance & longevity compoundsHerbals & botanicalsSupplement safety
Fitness
Cardio & intervalsStrength & muscleFunction & mobilityBones & joints
Sleep
Sleep durationRegularity & circadianQuality & disorders
Brain
Cognition & memoryMood & mental healthDementia & Alzheimer'sScreens & digital health
Metabolic
Weight & obesityGLP-1 & weight-loss drugsBlood sugar & diabetesCholesterol & heartBlood pressure
Verdicts

Tag

GLP-1

Page 6 of 6

A person holding a blue medical injection pen indoors
News

Apitegromab kept muscle on during tirzepatide weight loss

A Nature Medicine trial of 102 adults found adding the antibody apitegromab to tirzepatide cut lean-mass loss by 1.9 kilograms over 24 weeks, without slowing total weight loss.

Jul 25, 2026
A semaglutide injection pen resting on a surface
News

Semaglutide slowed biological aging clocks in a small trial

Researchers reanalyzed a 32-week trial of semaglutide in 84 adults and found the drug slowed several DNA-based clocks of biological aging. The aging analysis was exploratory, and the group studied was specific.

Jul 17, 2026
Search